1. Home
  2. JNVR vs SNGX Comparison

JNVR vs SNGX Comparison

Compare JNVR & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JNVR
  • SNGX
  • Stock Information
  • Founded
  • JNVR 2018
  • SNGX 1987
  • Country
  • JNVR United States
  • SNGX United States
  • Employees
  • JNVR N/A
  • SNGX N/A
  • Industry
  • JNVR Finance: Consumer Services
  • SNGX Biotechnology: Pharmaceutical Preparations
  • Sector
  • JNVR Finance
  • SNGX Health Care
  • Exchange
  • JNVR Nasdaq
  • SNGX Nasdaq
  • Market Cap
  • JNVR 7.3M
  • SNGX 7.4M
  • IPO Year
  • JNVR 2023
  • SNGX 1987
  • Fundamental
  • Price
  • JNVR $5.29
  • SNGX $2.32
  • Analyst Decision
  • JNVR
  • SNGX
  • Analyst Count
  • JNVR 0
  • SNGX 0
  • Target Price
  • JNVR N/A
  • SNGX N/A
  • AVG Volume (30 Days)
  • JNVR 18.8K
  • SNGX 621.8K
  • Earning Date
  • JNVR 03-27-2025
  • SNGX 03-14-2025
  • Dividend Yield
  • JNVR N/A
  • SNGX N/A
  • EPS Growth
  • JNVR N/A
  • SNGX N/A
  • EPS
  • JNVR N/A
  • SNGX N/A
  • Revenue
  • JNVR $1,820,969.00
  • SNGX $364,183.00
  • Revenue This Year
  • JNVR N/A
  • SNGX N/A
  • Revenue Next Year
  • JNVR N/A
  • SNGX $76.64
  • P/E Ratio
  • JNVR N/A
  • SNGX N/A
  • Revenue Growth
  • JNVR N/A
  • SNGX N/A
  • 52 Week Low
  • JNVR $3.37
  • SNGX $1.83
  • 52 Week High
  • JNVR $11.84
  • SNGX $14.88
  • Technical
  • Relative Strength Index (RSI)
  • JNVR 49.60
  • SNGX 36.12
  • Support Level
  • JNVR $4.88
  • SNGX $2.23
  • Resistance Level
  • JNVR $5.61
  • SNGX $2.39
  • Average True Range (ATR)
  • JNVR 0.63
  • SNGX 0.17
  • MACD
  • JNVR -0.03
  • SNGX 0.01
  • Stochastic Oscillator
  • JNVR 24.18
  • SNGX 22.12

About JNVR Janover Inc.

Janover Inc is a B2B fintech marketplace providing a platform for commercial property borrowers and lenders. It provides a technology platform that connects commercial mortgage borrowers looking for debt to refinance, build, or buy commercial property including apartment buildings to commercial property lenders including banks, credit unions, REITs, debt funds, and more looking to deploy capital into commercial mortgages. The firm caters to two consumer segments: lenders and borrowers. It derives the majority of its revenue from transaction fees.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Share on Social Networks: